application of oxazolines in asymmetric aldol reaction...
TRANSCRIPT
193
Chapter 3
Application of Oxazolines
in
Asymmetric Aldol Reaction
and
Henry Reaction
194
Introduction
Asymmetric Aldol Reaction
The controlled creation of new stereogenic centres is of paramount importance in
organic synthesis. Mainly three approaches are used to access chiral molecules, namely
resolution of stereoisomers, starting from enantiomerically pure isomers and by performing
asymmetric synthesis the through use of a chiral auxiliary, reagent or catalyst.
Use of asymmetric catalysts for accessing chirally pure organic compounds is by far
the most attractive and efficient option. The developments in the field of asymmetric catalysis
are inspired by the natural biochemical processes induced by biomolecules such as enzymes
and antibodies. Most of the early development was based on transition metal / chiral ligand
based asymmetric catalysis. Introduction of organic molecules capable of influencing the
basic organic reactions has ushered in the era of “organocatalysis” in modern chemistry. The
ability of organocatalyst to control the asymmetric transformation in the key step is attributed
mainly to supramolecular interactions, quite similar to the enzymes in the biochemical
reactions. Organocatalysts have advantages over the metal catalysed reactions, mainly it
reduces the use of metals which cause problems of disposal after completion of the reaction.
Elimination of the use of potentially toxic metal ion based catalysis in the wake of this
development goes well wih the advent of green chemistry and realization of the commitment
of the scientists towards the environmental cocerns.
The developments in the area are mostly focused on some of the carbon-carbon bond
forming asymmetric reactions such as aldol condensation and its varients, Michael reaction,
Baylis-Hillman reaction and Mannich reactions.1 In this chapter we will be focussing on
oganocatalytic application of chiral aminooxazolines in asymmetric aldol reaction,
preparation and charactersization of aminooxazolines have already been described in Chapter
2. Since this reaction has been developed, variety of organocatalysts have been desingned to
achieve good enantioselectivity in this organic transformation, most of them are prolione
derived organic molecules [Figure 1].
195
NH
O
OH
1
NHHN
HN
O S
HN
10
4
NH
NH
N
NN
32
HN
N
N
O
NH
5
NNHO
O
O
NH
Figure 1: Few examples of organocatalysts used for asymmetric aldol reaction
Hence, number of reports on aldol reaction proves the considerable attention on
application of organocatalysts in this carbon-carbon bond forming reaction. The major thurst
in this effort began with the pioneering work by Barbas, List and others when they utilized L-
proline to catalyse aldol reaction with excellent enantioselectivity.2
The L-proline 1 -catalyzed direct intermolecular asymmetric aldol reaction had not
been described by that time. Further, there were no asymmetric small-molecule aldol catalysts
that use an enamine mechanism. We initially studied the reaction of acetone with 4-
nitrobenzaldehyde in presence of L-proline 1 (30 mol %) in DMSO/acetone (4:1) at room
temperature for 4 h furnished aldol product (R)-8 in 68% yield and 76% ee [Scheme 1].2a
Variety of commercially available chiral amino acid have also been screened for this study
under the same condition. However, primary amino acids and acyclic secondary amino acids
failed to give significant amounts of the desired product.
Scheme 1: Asymmetric Aldol Reaction using L-Proline as Organocatalyst
It is widely accepted that the organocatalysed aldol reactions follow either acid
assisted enamine route [Scheme 2] or the base induced enol-enolate pathway [Scheme 3]. For
aldol reaction of unactivated ketones the enamine mechanism appears favourable, while the
base induced enol-enolate pathways is less likely due to the low acidity of the -protons.
196
Scheme 2: Mechanistic approach via Enamine intermediate
This mechanism involved several steps, including the nucleophilic attack of the amino
group (a), the dehydration of the carbinol amine intermediate (b), the deprotonation of the
iminium species (c), the carbon-carbon bond forming step (d), and both steps of the
hydrolysis of the iminium-aldol intermediate (e) and (f). The enantioselectivity can be
explained with a metal free version of a Zimmerman-Traxler type transition state.17 The
tricyclic hydrogen bonded framework provides for enantiofacial selectivity.
Scheme 3: Enol - Enolate pathway
Since these reports many applications of proline induced organocatalytic reactions
have been reported with varied degree of selectivity and mechanistic investigations. Besides
proline other chiral organic molecules based on thiourea,4 thiazolidine,5 cinchona alkaloids,6
peptides,7 cabohydrates8 etc. have been screened successfully as organocatalysts for
asymmetric reactions.
197
Recently an elegant combination of amino oxazoline and proline has been prepared
and tested for inducing chirality in intermolecular aldol reaction.9a These type of prolinamide-
oxazolines are amongst a series of modifications designed on the basic amino acid unit of
proline where a second chiral element has been introduced. Such derivatives with two chiral
units have been more selective as compared to some of the prolinamides prepared with achiral
amines.9b This series of prolinamide-oxazolines are neutral molecules in nature as the
carboxylic acid of proline is blocked by the amide group. Hansen et al. reported an interesting
approach for the preparation of polymer-supported proline via acrylic copolymerization.9c
These functionalized polymer systems have proven to be very efficient for asymmetric aldol
reactions and offer an advantageous recyclability. Cui and co-workers have also developed
chitosan immobilizecd proline10 and polyvinyl chloride supported proline11 as catalysts for
direct aldol reaction with good efficiency and performance. Inspiring from these reports, Cui
has utilized the ability of thiourea group being a weak Bronsted acid which able to activate
the electrophilic substrate via double-hydrogen bonding, to synthesize polymer supported
chiral organocatalyst 3 having incorporated L-proline and thiourea moieties in it [Figure 1]
and [Scheme 4].
Scheme 4: Asymmetric aldol reaction using polymer supported thiourea based organocatalyst 3
A cooperative catalyst system between a chiral transition-metal catalyst of the ligand
12 and achiral thiourea based Organocatalyst 11 was developed for highly diastereo- and
enantioselective aldol reaction of methyl -isocyanoacetate 13 and variety of aldehydes
[Scheme 5].4
198
CF3
NH
F3C NH
S
CF3
CF3
N
H
NHH
O
OH
O
HO
H
OMe
OMe
CN COOMeR
O
H+ R
NO
COOMe
11
Ln*
11 (20 mol%)DBU (20 mol%)
CoI2/Ln* (12) (10 mol%)
12
THF/1,4-dioxane (4:1)
23oC, 18h13 > 98% ee
> 20:1 dr
Scheme 5: Application of thiourea based achiral Organocatalyst 11 for asymmetric aldol reaction
For strong H-bonding to the carbon in isocyanides, an anion bonding interaction I
between thiourea and methyl -isocyanoacetate was established. The thiourea assisted
enolates would be capable of coordinating to a stereogenic metal centre in a more organised
fashion II [Scheme 6]. Based on spectroscopic investigations, the anion-bonding interaction
of the carbon atom of isocyanide and the N-H of the thiourea were evident.
Scheme 6: Mechanistic approach for the application of cooperative catalyst 11
Saccharide-derived bi-functional amine-thiourea 17 catalyst was developed by Ma et
al. and used in direct aldol condensation of trifluoroacetaldehyde methyl hemiacetal 14 with
benzaldehyde 15 to produce 16 with good stereoselectivity [Scheme 7].12
H C
HN
N
SR
R
NCOOMe
(I)
B
[MLn*]+
R'CHO
BH+
HC
H
NN
S
RR
N
O
MeO
MLn*
O
R'
(II)
BH+ B
H*
*
COOMe
R'-[MLn*]
-Thioureaproduct
199
Scheme 7: Saccharide-derived amine-thiourea organocatalyst 17 in aldol reaction
It was also noticed that nitrosobenzene could act as an electrophilic aminooxylating
reagent, inspring by this thought Hayashi and co-workers have examined the reaction between
a ketone and nitrosobenzene in the presence of chiral organocatalyst 1 or 3, and have
discovered the direct asymmetric -aminooxylation of ketones gave remarkably excellent
enantioselectivity up to 98% [Scheme 8].13
Scheme 8: Organocatalyzed asymmetric aminooxylation of ketones
A set of enantiopure thiazolidine-based organocatalysts have been by Schneider. In
particular, organocatalyst 20 exhibited the highest catalytic performance working in an
aqueous medium. It catalyzed the direct catalytic asymmetric intermolecular aldol reaction
between unmodified ketones and an aldehyde with excellent stereocontrol and furnished the
corresponding aldol products in up to 99% ee [Scheme 9].5
H
O
O
OOH
+
NH
O CH2Ph
Ph
OH
PhS
NH
20 (10 mol%)
Brine rt 120 h
21 99% ee15 7
20
Scheme 9: Application of thiazolidine-based organocatalyst 20 in asymmetric aldol reaction
Over the years, number of cinchona alkaloid and their derivatives have been
successfully applied in a wide diversity of organocatalytic reactions,14 acting as chiral-base,15
200
phase transfer16 and nucleophilic catalysts.17 Hence, due to their extraordinary catalytic
activity in organic transformations, Xiao and co-workers have developed a set of class of
chiral oragnocatalysts which incorporate the properties of well established proline and
cinchona alkaloid in single molecule and applied them for asymmetric aldol reaction which
resulted in to high degree of enantioselectivity [Scheme 10].18
Scheme 10: Cinchona alkaloid based organocatalyst 4 for aldol reaction
Guan et al. examined the application of bi-functional recoverable and reusable L-
Prolinamide oranocatalyst 5. This Organocatalyst was applied to the aldol reactions of
aromatic and heteroaromatic aldehydes with cyclic as well as acyclic ketones, and anti-aldol
product could be obtained with up to 1:99 syn:anti ratio and 98% ee. This type of
organocatalyzed asymmetric aldol reaction can be performed on a large-scale which offers the
possibility for applications in industry without affecting the enantioselectivity [Scheme 11].19
Scheme 11: Use of Prolinamide derived Organocatalyst 5 in aldol reaction
Interestingly, another class of carbohydrate based chiral organocatalysts 22 and 23
have also been developed to utilized the presence of the highly functionalized and having
several stereogenic centres which provides additional effect on stereoselectivity in aldol
reaction [Figure 2].8
Figure 2: Carbohydrate based oragnocatalysts 22 and 23
201
Many researchers have also studied isatin 24 as an acceptor of enolate in the
asymmetric organocatalyzed aldol reaction.7a,8b,20 Number of oragnocatalysts 25-28 have been
utilized for this purpose, some of them are listed below [Figure 3].21
Figure 3: List of Organocatalysts 25-28 used for aldol reaction of isatin 24
Using these oragnocatalysts for the asymmetric aldol reaction of isatin and acetone, 25
was found to be less effective giving only 2% ee for the R-isomeric product 29 and also
catalyst 26 was not at all exhibited stereoselectivity under the same condition. But the
catalysts derived by combination of thiourea and cinchona alkaloid derivatives, 27 and 28,
gave interesting results. Catalyst 27 having phenyl substituent at thiourea moiety resulted with
61% ee without changing stereochemistry of the chiral centre in aldol product whereas in case
of catalyst 28 having comparatively bulky 3,5-ditrifluormehhylphenyl substituent at thiourea
moiety exhibited same aldol product 29 with 85% ee [Scheme 12].21
Scheme 12: Organocatalyzed asymmetric aldol reaction of isatin 24
202
Asymmetric Henry Reaction
Among the C-C bond forming reactions, the nitroaldol (Henry) reaction is one of
the classical reactions in organic synthesis.22 The Henry reaction is a useful technique in the
area organic chemistry due to the synthetic utility of its corresponding products, as they can
be easily converted to other useful synthetic intermediates. These conversions include
subsequent dehydration to yield nitroalkenes, oxidation of the secondary alcohol to yield α-
nitro ketones, or reduction of the nitro group to yield β-amino alcohols. Many of these uses
have been exemplified in the syntheses of various pharmaceuticals including the β-blocker
(S)-propranolol,23 HIV protease inhibitor Amprenavir, and construction of the carbohydrate
subunit of the anthracycline class of antibiotics, L-Acosamine.24 It is also well known that
the nitroaldol products find increasing applications in the synthesis of natural products,
polyamino alcohols and polyhydroxylated amides. Generally, the nitroaldol reaction
involves the addition of a nitronate ion to a carbonyl compound. The nitronate ion can be
generated in situ by the deprotonation of a nitroalkane with an external base. The addition
is facilitated either by a Lewis acid catalyst or by a suitable bi-functional catalyst, while
the former activates the carbonyl partner, the latter works as a Lewis acid- Bronsted base
which activates and bring both reactants together.25
Many attempts to develop catalytic asymmetric nitroaldol reaction variants have
therefore been made.26 Out of the great number of metal-based catalysts, copper salts have
become the most widely used examples, because copper is a relatively cheap and low-toxicity
metal with excellent chelating properties.27
Recently, Gong has reported the synthesis of number of N,N-chiral ligands 30-37
derived from (-)-exo-bornylamine and also 38 from (+)-menthylamine [Figure 4]. They have
screened these ligands for Cu (II)-catalyzed asymmetric Henry reaction of variety of
aldehydes and nitromethane which exhibited excellent results in terms of conversion as well
as stereoselectivity [Scheme 13].28
Figure 4: Ligands used for Cu-catalyzed Asymmetric Henry reaction
203
Among these ligands, 30-34, 36 and 38 gave good results with enantioselectivities up
to 92%, whereas ligand 35 and 37 were not showing any stereoselectivity. All the ligands
produced Henry product 39 with S-isomeric form except ligand 38 where stereoselectivity
was inversed.
Scheme 13: Cu-catalyzed asymmetric Henry reaction
Variety of chiral oxazolinyl ligands have also contributed for metal catalyzed
asymmetric Henry reaction which showed excellent outcome for this reaction. A series of
novel C2-symmetric bis(thiazoline) ligands as well as bis(oxazoline) ligands have been
developed and screened for Cu-catalyzed asymmetric Henry reaction to exhibit good results.29
Another class of chiral oxazoline ligands have also been found to be successful for Cu-
catalyzed Henry reaction.30 Also certain Schiff base-Cu complexes were also reported to show
remarkable input for this nitroaldol reaction.31 Ligands derived from 1,2-diaminocyclohexane
framework were also developed to contribute for asymmetric Henry reaction with excellent
stereoselectivity.32
Considering these wide applications in organic transformations, we have screened our
aminooxazolines for asymmetric aldol reaction as well as asymmetric Henry reaction and the
results are encouraging which are well documented in this chapter.
204
Result and Discussion
Asymmetric Aldol Reaction
Since the chiral amino oxazoline is a weak base we have screened number of
synthesized aminooxazolines 40-55 as oragnocatalysts for asymmetric aldol reaction with
sufficiently activated enolate acceptors. List of the aminooxazolines are shown in Figure 5.
NH
N
O
42
NH
N
O
41
NH2
N
O
40
Ph
O
NH
N
O
43
NH
N
O
NH
N
O
44 45
NH
N
O
46
NH
N
O
Br47
NH
N
O
NH
N
O
48 49
Figure 5: List of aminooxazolines 40-55 used as oragnocatalysts for asymmetric aldol reaction
205
With this concept we utilized 4-nitro benzaldehyde as the standard aldehyde and
scanned the conditions with number of amino oxazolines [Scheme 14] and [Table 1].
O2N
O
H 40-55 as organocatalysts
O
O2N
OH O
6
7
8
Scheme 14: Aminooxazoline catalyzed asymmetric aldol reaction
Recently polyethylene glycol was used as solvent for L-proline mediated aldol
reaction.33 Besides this we have also used other solvents [Table 1]. Reaction proceeded with
moderate results with PEG-400 and THF, while the configuration of the -hydroxy compound
8 was established as “R” by comparison of the observed optical rotation.
Table 1: Screening of amino oxazoline 47 (20 mol %) for
standard example of 4-nitro benzaldehyde and acetone (4
eq. Except for 3).
No Solvent Temp oC/ Ttime h
Yield/% % ee
(R)
1 PEG-400 30 / 24 79 16
2 PEG-400 5-8 / 24 61 51
3 Acetone 5-8 / 24 71 40
4 ACN 5-8 / 24 33 75
5 Toluene 5-8 / 24 16 91
6 THF 5-8 / 24 33 75
7 THF 5-8 / 72 48 71
206
The synthesized series of ligands were then scanned under the optimized condition of
THF as solvent for 72 h reaction time for 4-nitro benzaldehyde 6 and acetone 7. The results
are summarised in Table 2, in most cases the yield and selectivity was moderate to good. The
ligand with free –NH2 group (40) and –NHCOPh (41) were both ineffective to assist this
reaction, while derivatives prepared from tert-leucinol show good selectivity.
Table 2: Screening of amino oxazolines (20 mol %) for standard example of 4-nitro
benzaldehyde 6 and acetone 7 (4 eq.).
No Amino
oxazoline
Yield of
8
(%)
ee of
8-(R)
(%)
No Amino
oxazoline
Yield of
8
(%)
ee of
8-(R)
(%)
1 40 NR -- 9 49 59 39
2 41 NR -- 10 50 57 63
3 43 68 76 11 51 59 71
4 44 66 76 12 52 60 76
5 45 65 63 13 53 56 75
6 46 52 86 14 54 60 75
7 47 48 79 15 55 62 76
8 48 51 71
For all reactions: Solvent = THF; Reaction Temp = 5-8 oC; Time 72 h.
NR = no reaction.
The amino oxazoline 46 and 47 were found to show consistent results with both
good conversion and enantioselectivity. Hence, these were then investigated for a few
aromatic aldehydes attached with electron withdrawing substituents, results are
tabulated in Table 3.
207
Table 3: Screening of amines 46 and 47 for select examples.
-hydroxyketone
(R)
% Yield (% ee)
1
2
3
4
5
O2N
OH O
OH O
NO2
OH O
O2N
OH O
ClOH O
Br
with 46
54 (91)48 (79)
69 (91)72 (84)
73 (74)
68 (70)
47 (66)52 (61)
49 (84)
58 (57)
6 R = 4-NO2
56 R = 2-NO2
58 R = 3-NO2
60 R = 4-Cl
62 R = 4-Br
8
57
59
61
63
with 47No RC6H4CHO
We have also tried this system for the reaction of isatin 24 and acetone 7 in presence
of amino oxazoline 46 and the aldol product 29-(S) was isolated in moderate
enantioselectivity [Scheme 15].
Scheme 15: Application for aldol reaction of isatin 24 with acetone 7.
208
The major advantage of amino oxazolines is its high solubility in almost all routine
organic solvents, unlike proline. Since the reaction is assisted by a base and condition is
neutral (no acid additive is used) we propose that the reaction must be following enol-enolate
pathway. The enantioselectivity of the amino oxazolines for aldol reaction is mainly
controlled by the size and shape of the chiral substituent on the oxazoline ring and it is almost
independent of the group attached on the amino unit. However, the derivative 40 with primary
amino group as well as the benzoyl derivative 41 failed to catalyze this reaction. It is possible
that in the former the condensation of aldehyde with primary amine is a competing reaction
while the neutral nature of benzoyl derivative is not favoring the enol formation in the latter
case.
It is also noteworthy to mention that the acid labile amino oxazoline remains intact
after the reaction is complete (tlc), however, so far we have not made any attempts to recover
and recycle the catalyst.
Asymmetric Henry Reaction
We have also screened some of our chiral aminooxazolies as ligands for Cu-catalyzed
asymmetric Henry reaction of 4-nitrobenzaldehyde 6 and nitromethane to afford nitroaldol
product 64 with good conversion and modest enantioselectivity. We have screened 43, 44 and
46 as ligands and Cu salts to achieve the standard condition for this reaction [Scheme 16] and
[Table 4].
Scheme 16: Application of aminooxazolines in asymmetric Henry reaction
209
Table 4: Experimental parameters in search of standard conditon for Henry reaction
No. Cu Salt (mol%)
Ligand (mol %)
Additive (mol %)
Temperature (oC)
Time (h)
Yield of 64 (%)
ee of
64 (%)
1 Cu(OTf)2
(5%) 43 (10%) -- rt 72 46 Racemic
2 CuI (5%) 43 (10%) -- rt 72 41 Racemic
3 Cu(OAc)2.H2O
(5%) 43 (10%) -- rt 72 68 Racemic
4 Cu(OTf)2
(5%) 43 (10%) -- 5-8 72 trace --
5 Cu(OAc)2.H2O
(5%) 43 (10%) -- 5-8 72 63 25 (S)
6 CuCl2.H2O
(5%) 43 (10%) -- 5-8 72 NR --
7 Cu(OAc)2.H2O
(10%) 43 (10%) -- 5-8 72 62 21(S)
8 Cu(OAc)2.H2O
(5%) 43 (10%) DIPEA
(100 mol%) 5-8 72 81 Racemic
9 Cu(OAc)2.H2O
(5%) 44 (10%) -- 5-8 72 69 26 (S)
10 Cu(OAc)2.H2O
(5%) 46 (10%) -- 5-8 72 74 31 (S)
NR = no reaction. Stereochemistry was confirmed by the reportd optical rotation values in literature.
Initially we have used copper(II) triflate as a metal source and 43 as ligand in 1:2
proportion to make effective comlex to catalyse reaction of 4-nitrobenzaldehyde 6 and
nitromethane in dry ethanol at room temperature. Allthough the conversion was encouraging,
there was no selectivity observed in this reaction. Similar result was obtained with Cu (I)
iodide under the same experiental parameters. Cu(II) acetate salt gave the racemic product but
the yield was on the higher side which encouraged us to develop the condition using this
system. We tried this reaction with Cu(II) acetate (5 mol%) and ligand 43 (10 mol%) at lower
temperature around 5-8 oC, surprisingly it exhibited stereoselectivity of 25% ee for the
product (S)-64 in 72h. Under the same condition Cu(II) triflate and chloride were non-
productive at all. We have also perfomed a reaction with equimolar ammount of salt and
ligands which resulted with almost same conversion but slightly lower selectivity. Some
210
reports have prompted us to use DIPEA as a base with a intention to increase the
stereoselectivity of the product due to its bulky nature, but on the contrary it yielded the
product in racemic form with higher conversion. Hence we considered the experimental
condition shown in entry-5/Table 4 as a standard for the screening of other ligands. We have
screened two more ligands 44 and 46, earlier was having benzyl substituent at the oxazoline
ring and tert-butyl in the later. They both were equally effective as 43 which had iso-propyl
substituent at the oxazoline ring, resulted with 26% and 31% enantioselectivity respectively
for the (S)-64 without affecting the stereochemistry at the chiral centre.
Unfortunately, this catalyst system did not work for the other aromatic aldehydes.
211
Experimental Section
Reagents were purchased from Sigma-Aldrich Chemicals Limited, SD Fine, Sisco,
Qualigens, Avara Chemicals Limited etc. Tetrahydrofuran was refluxed over sodium
benzophenone-ketyl and freshly distilled prior to its use. Thin Layer Chromatography was
performed on Merck 60 F254 Aluminium coated plates. The spots were visualized under UV
light or with iodine vapour. All the compounds were purified by column chromatography
using Sisco Research Laboratory silica gel (60-120 mesh) and neutral alumina. All reactions
were carried out under an inert atmosphere (nitrogen) unless other conditions are specified.
NMR Spectra were recorded on 400 MHz Bruker Avance 400 Spectrometer (400 MHz for
1H-NMR & 100 MHz for 13C-NMR) with CDCl3 as solvent and TMS as internal standard.
Signal multiplicity is denoted as singlet (s), doublet (d), doublet of doublets (dd), triplet (t),
quartet (q) and multiplet (m). Mass spectra were recorded on Thermo-Fischer DSQ II
GCMS instrument. IR Spectra were recorded on a Perkin-Elmer FTIR RXI spectrometer as
KBr pallets. Optical rotations were measured on Jasco P-2000 polarimeter. Melting
points were recorded in Thiele’s tube using paraffin oil and are uncorrected. For the HPLC
analysis chiral L u x 5μ Amylase – 2, chiral Diacel OD-H column and Chiralpak IC column
were used on Shimadzu LC-20AD having UV-Vis detector.
Asymmetric Aldol Reaction
Synthetic Procedures:
(R)-4-Hydroxy-4-(4-nitrophenyl)butan-2-one (8):
Amino oxazoline 46 (0.062 g, 0.20 mmol, 20 mol %) and acetone 7 (0.23 g, 4.0 mmol) was
stirred in dry THF at 5 – 8 oC for 30 min. 4-Nitrobenzaldehyde 6 (0.151 g, 1.0 mmol) was
added to the resulting solution and stirred at the same temperature for 72 hrs. Solvent was
evaporated under reduced pressure then 20 mL water was added to the crude mixture and
extracted 3 x 20 mL with ethylacetate, combined organic layer was dried over sodium
sulfate and solvent was evaporated on rotary evaporator. The crude material was purified by
column chromatography using 60 – 120 mesh silica gel and ethylacetate : petroleum ether as
eluent to afford aldol product 8 (R isomer) with (0.111g, 54%) light yellow solid
212
M.P. 58 oC (Lit.34 59 – 61 oC). = +35.30 (c 0.20, CHCl3). [Lit.35 = +35.2 (c 0.20,
CHCl3), 81% ee]
1H-NMR (400 MHz, CDCl3): δ 8.23 – 8.20 (m, 2H), 7.56 – 7.53 (dd, J = 2.0 & 6.4 Hz, 2H),
5.29 – 5.25 (m, 1H), 3.60 (d, J = 3.2 Hz, 1H), 2.92 – 2.80 (m, 2H), 2.23 (s, 3H).
IR (KBr): 3438, 3082, 2905, 1708, 1604, 1520, 134 cm-1
MS (EI): m/z (%) 208.73 (51), 190.85 (100), 173.70 (76), 152.05 (30), 104.47 (10), 90.81
(11), 76.83 (14), 57.84 (11).
Enantiomeric excess 91% determined by HPLC [Column: Lux 5μ Amylose-2; Solvent
system: Hexane/Iso-propanol (90:10); Flow rate: 1.0 mL/min; λmax = 254 nm; tR = 26.6 min
(minor, S isomer), tR = 31.7 min (major, R isomer)].
(S)-3-Hydroxy-3-(2-oxopropyl)indolin-2-one (29):
In a clean dry 25 mL flask, mixture of amino oxazoline 46 (0.063 g, 0.20 mmol, 20 mol %)
and acetone 7 (0.23 g, 4.08 mmol) was mixed in dry THF at 5 – 8 oC which then stirred for
30 min. To this clear solution, isatin 24 (0.15 g, 1.02 mmol) was added and stirred at the
same temperature for 72 hrs. Solvent was evaporated under reduced pressure then 20 mL
Water was added to the crude mixture and extracted 3 x 20 mL with ethylacetate, combined
organic layer was dried over sodium sulfate and solvent was evaporated on rotary
evaporator. The crude material was purified by Column Chromatography using 60 – 120
mesh silica gel; mixture of ethylacetate and petroleum ether as eluent to afford aldol product
29 (0.097 g, 46%) as off white solid
M.P. 166 – 168 oC (Lit.20 169 – 170 oC). = -21.11 (c 0.03, CH3OH)
[Lit.21 = -20.0 (c 0.03, CH3OH), 61% ee]
1H-NMR (400 MHz, DMSO): δ 10.09 (s, 1H), 7.16 (d, J = 7.2 Hz, 1H), 7.12 – 7.08 (t, J =
7.6 Hz, 1H), 6.87 – 6.83 (t, J = 7.2 Hz, 1H), 6.75 (d, J = 8.0 Hz, 1H), 5.92 (d, J = 1.6 Hz, 1H),
3.16 (d, J = 16.4 Hz, 1H), 2.98 (d, J = 16.4 Hz, 1H), 1.99 (s, 3H).
213
IR (KBr): 3362, 3260, 2358, 1718, 1621, 1472, 1365, 1077, 752 cm-1
MS (EI): m/z (%) 204.80 (100), 161.47 (80), 147.81 (92), 120.01 (43), 91.74 (19).
Enantiomeric excess 62% determined by HPLC [Column: Chiralcel OD-H; Solvent system:
Hexane/Iso-propanol (70:30); Flow rate: 1.0 mL/min; λmax = 254 nm; tR = 14.7 min (minor,
R isomer), tR = 20.9 min (major, S isomer).
(R)-4-Hydroxy-4-(2-nitrophenyl)butan-2-one (57):
In 25 mL flask, amino oxazoline 46 (0.062 g, 0.20 mmol, 20 mol %) and acetone 7 (0.23 g,
4.0 mmol) was stirred in dry THF at 5 – 8 oC for 30 min. To the resulting solution 2-
Nitrobenzaldehyde 56 (0.151 g, 1.0 mmol) was added and stirred at the same temperature for
72 hrs. Solvent was evaporated under reduced pressure then 20 mL water was added to the
crude mixture and extracted 3 x 20 mL with ethylacetate, combined organic layer was dried
over sodium sulfate and solvent was evaporated on rotary evaporator. The crude material
was purified by column chromatography using 60 – 120 mesh silica gel and ethylacetate :
petroleum ether as eluent to afford aldol product 57 (R isomer) (0.142 g, 69%) light yellow
solid.
M.P. 58 – 60 oC (Lit.36 59 - 61 oC). = -157.57 (c 0.3, CHCl3). [lit.37 = -141.0 (c
0.5, CHCl3), 91% ee]
IR (KBr): υ 3420, 3080, 2924, 1715, 1613, 1528, 1352 cm.-1
1H-NMR (400 MHz, CDCl3): δ 8.00 – 7.98 (dd, J = 1.2 & 8.4 Hz, 1H), 7.93 – 7.91 (dd, J =
1.6 & 8.0 Hz, 1H), 7.71 – 7.67 (m, 1H), 7.48 – 7.44 (m, 1H), 5.71 – 5.68 (dd, J = 2.0 & 8.2
Hz, 1H), 3.73 (bs, 1H), 3.19 – 3.14 (m, 1H), 2.78 – 2.71 (m, 1H), 2.26 (s, 3H).
IR (KBr): 3420, 3080, 2924, 1715, 1613, 1528, 1352 cm-1
MS (EI): m/z (%) 190.94 (M+-18, 5), 151.17 (34), 131.78 (77), 103.98 (100), 90.83 (26),
76.61 (40).
Enantiomeric excess 91% determined by HPLC [Column: Lux 5μ Amylose-2; Solvent
system: Hexane/Iso-propanol (90:10); Flow rate: 1.0 mL/min; λmax = 220 nm; tR = 36.7 min
(minor, S isomer), tR = 40.4 min (major, R isomer)].
214
(R)-4-Hydroxy-4-(3-nitrophenyl)butan-2-one (59):
Mixture of amino oxazoline 46 (0.062 g, 0.20 mmol, 20 mol %) and acetone 7 (0.23 g, 4.0
mmol) was stirred in dry THF at 5 – 8 oC for 30 min. To the resulting solution 3-
Nitrobenzaldehyde 58 (0.151 g, 1.0 mmol) was added and stirred at the same temperature for
72 hrs. Solvent was evaporated under reduced pressure then 20 mL water was added to the
crude mixture and extracted 3 x 20 mL with ethylacetate, combined organic layer was dried
over sodium sulfate and solvent was evaporated on rotary evaporator. The crude material
was purified by column chromatography using 60 – 120 mesh silica gel and ethylacetate :
petroleum ether as eluent to afford aldol product 59 (R isomer) (0.154 g, 73%) off white
solid.
M.P. 50 oC (Lit.38 50 – 52 oC). = +63.13 (c 0.5 in CHCl3). [Lit.39 = +62.1 (c 0.35,
CHCl3), 87% ee]
1H-NMR (400 MHz, CDCl3): δ 8.25 (s, 1H), 8.15 – 8.13 (m, 1H), 7.72 (d, J = 7.6 Hz, 1H),
7.56 – 7.52 (m, 1H), 5.28 – 5.25 (m, 1H), 3.71 (bs, 1H), 2.91 – 2.89 (m, 2H), 2.24 (s, 3H).
IR (KBr): 3419, 3087, 2920, 1710, 1620, 1534, 1354 cm-1
MS (EI): m/z (%) 191.55 (M+-18, 100), 150.29 (77), 118.82 (28), 104.83 (74), 90.85 (39),
76.92 (89), 57.75 (66).
Enantiomeric excess 74% determined by HPLC [Column: Lux 5μ Amylose-2; Solvent
system: Hexane/Iso-propanol (90:10); Flow rate: 1.0 mL/min; λmax = 220 nm; tR = 28.7 min
(major, R isomer), tR = 40.4 min (major, S isomer)].
(R)-4-(4-Chlorophenyl)-4-hydroxybutan-2-one (61):
In a clean dry 25 mL flask, mixture of amino oxazoline 46 (0.062 g, 0.20 mmol, 20 mol %)
and acetone 7 (0.23 g, 3.98 mmol) was stirred in dry THF at 5 – 8 oC for 30 min. To the
215
resulting solution 4-Chlorobenzaldehyde 60 (0.14 g, 0.996 mmol) was added and stirred at
the same temperature for 72 hrs. Solvent was evaporated under reduced pressure then 20 mL
water was added to the crude mixture and extracted 3 x 20 mL with ethylacetate, combined
organic layer was dried over sodium sulfate and solvent was evaporated on rotary
evaporator. The crude material was purified by column chromatography using 60 – 120 mesh
silica gel and ethylacetate : petroleum ether as eluent to afford aldol product 59 (R isomer)
(0.093 g, 47%) as white solid.
M.P. 50 oC (Lit.35 47 – 50 oC). = +55.17 (c 0.5, CHCl3). [Lit.37 = +62.7 (c 0.48,
CHCl3), 93% ee]
1H-NMR (400 MHz, CDCl3): δ 7.35 – 7.29 (m, 4H), 5.16 – 5.13 (m, 1H), 3.42 (d, J = 2.8
Hz, 1H), 2.90 – 2.78 (m, 2H), 2.22 (s, 3H).
IR (KBr): υ 3425, 3000, 2901, 1717, 1600, 1321, 571, 490 cm-1
MS (EI): m/z (%) 200 (8), 197.74 (39), 182.16 (10), 180.21 (14), 164.75 (13), 144.88 (31),
142.20 (15), 140.72 (100), 112.73 (26), 76.86 (57).
Enantiomeric excess 66% determined by HPLC [Column: Lux 5μ Amylose-2; Solvent
system: Hexane/Iso-propanol (90:10); Flow rate: 1.0 mL/min; λmax = 220 nm; tR = 28.5 min
(major, R isomer), tR = 31.3 min (major, S isomer).]
(R)-4-(4-Bromophenyl)-4-hydroxybutan-2-one (63):
O
Br
OH
Mixture of amino oxazoline 46 (0.062 g, 0.20 mmol, 20 mol %) and acetone 7 (0.23 g, 4.0
mmol) was stirred in dry THF at 5 – 8 oC for 30 min. To the resulting solution 4-
Bromobenzaldehyde 62 (0.185 g, 1.0 mmol) was added and stirred at the same temperature
for 72 hrs. Solvent was evaporated under reduced pressure then 20 mL water was added to
the crude mixture and extracted 3 x 20 mL with ethylacetate, combined organic layer was
dried over sodium sulfate and solvent was evaporated on rotary evaporator. The crude
material was purified by column chromatography using 60 – 120 mesh silica gel and
ethylacetate : petroleum ether as eluent to afford aldol product 63 (R isomer) (0.120 g, 49%)
as off white solid
216
M.P. 58 oC (Lit.38 58 - 60 oC). = +26.61 (c 0.51 in CHCl3) [Lit.40 = +47 (c 0.5,
CHCl3), 95% ee]
1H-NMR (400 MHz, CDCl3): δ 7.50 – 7.48 (dd, J = 1.6 & 6.4 Hz, 2H), 7.27 – 7.24 (m, 2H),
5.15 – 5.12 (m, 1H), 3.40 (d, J = 3.2 Hz, 1H), 2.90 – 2.78 (m, 2H), 2.22 (s, 3H).
IR (KBr): 3247, 3067, 3027, 2844, 1718, 1605, 1322, 1077, 1051, 1028,
749, 687, 572, 544 cm-1
MS (EI): m/z (%) 244 (34), 242.04 (33), 226.11 (25), 225.21 (19), 186.98 (73), 185.00
(100), 158.99 (17), 156.96 (31), 76.84 (87).
Enantiomeric excess 84% determined by HPLC [Column: Chiralpak IC; Solvent system:
Hexane/Iso-propanol (90:10); Flow rate: 1.0 mL/min; λmax = 254 nm; tR = 31.4 min (minor,
S isomer), tR = 32.4 min (major, R isomer)].
217
Asymmetric Henry Reaction
Synthetic Procedure:
(S)-2-Nitro-1-(4-nitrophenyl)ethanol (64):
In a clean dry 10 mL flask, Cu(OAc)2.H2O (0.010 g, 0.049 mmol, 5 mol%) was dissolved in
dry ethanol (3 mL) at room temperature then amino oxazoline 46 (0.020 g, 0.099 mmol, 10
mol %) was added to the same flask at 5-8 oC and stirred for 1 h at the same temperature. To
this green coloured catalyst solution, nitromethane (0.625 g, 9.93 mmol) was added drop wise
at the same temperature and stirred for additional 30 min. Then 4-nitrobenzaldehyde (0.150 g,
0.993 mmol) was added to the same flask and stirred for 72 h at 5-8 oC. Solvent was
evaporated under reduced pressure and resulting gummy crude product was purified by
Column Chromatography using 60-120 mesh silica gel; mixture of ethylacetate and
petroleum ether as eluent to afford Henry product 64 (0.157 g, 74%) as off white solid.
M.P. 80-82 oC (Lit.41 80-85 oC); = +12.01 (c 1.01, CH2Cl2) [Lit.31a = +35.9 (c
1.01, CH2Cl2), 92% ee]
1H-NMR (400 MHz, CDCl3): δ 8.28 – 8.26 (dd, J = 2.0 & 6.8 Hz, 2H), 7.63 (d, J = 8.8 Hz,
2H), 5.64 – 5.60 (m, 1H), 4.64 – 4.55 (m, 2H), 3.20 (d, J = 4.0 Hz, 1H).
IR (KBr): 3507, 2920, 2849, 1553, 1514, 1411, 1381, 1346, 1072, 849 cm-1
Enantiomeric excess 31% determined by HPLC [Column: Chiralcel OD-H; Solvent system:
Hexane/Iso-propanol (85:15); Flow rate: 0.8 mL/min; λmax = 254 nm; tR = 19.8 min (minor,
R isomer), tR = 24.8 min (major, S isomer).
218
Spectral Data for Asymmetric Aldol Products
1H-NMR of the compound 8 (400 MHz, CDCl3)
1H-NMR of the compound 29 (400 MHz, DMSO)
219
1H-NMR of the compound 57 (400 MHz, CDCl3)
1H-NMR of the compound 59 (400 MHz, CDCl3)
220
1H-NMR of the compound 61 (400 MHz, CDCl3)
1H-NMR of the compound 63 (400 MHz, CDCl3)
221
HPLC Data for Aldol Products
Method For HPLC Analysis of the compound 8:
Solvent System: n-Hexane: Iso-propanol (90:10)
Flow rate: 1 mL/min.
Detector: UV-Vis (max – 254 nm)
Chiral Column: Lux 5μ Amylose-2
racemic
222
Method For HPLC Analysis of the compound 29:
Solvent System: n-Hexane: Iso-propanol (70:30)
Flow rate: 1 mL/min.
Detector: UV-Vis (max – 254 nm)
Chiral Column: Chiralcel OD-H
223
Method For HPLC Analysis of the compound 57:
Solvent System: n-Hexane: Iso-propanol (90:10)
Flow rate: 1 mL/min.
Detector: UV-Vis (max – 220 nm)
Chiral Column: Lux 5μ Amylose-2
Method For HPLC Analysis of the compound 59:
Solvent System: n-Hexane: Iso-propanol (90:10)
Flow rate: 1 mL/min.
Detector: UV-Vis (max – 220 nm)
Chiral Column: Lux 5μ Amylose-2
224
Method For HPLC Analysis of the compound 61:
Solvent System: n-Hexane: Iso-propanol (90:10)
Flow rate: 1 mL/min.
Detector: UV-Vis (max – 220 nm)
Chiral Column: Lux 5μ Amylose-2]
Method For HPLC Analysis of the compound 63:
Solvent System: n-Hexane: Iso-propanol (90:10)
Flow rate: 1 mL/min.
Detector: UV-Vis (max – 254 nm)
Chiral Column: Chiralpak IC
225
Spectral Data for Asymmetric Henry Product
1H-NMR of the compound 64 (400 MHz, CDCl3)
226
HPLC Data for Henry Products
Method For HPLC Analysis of the compound 64:
Solvent System: n-Hexane: Iso-propanol (85:15)
Flow rate: 0.8 mL/min.
Detector: UV-Vis (max – 254 nm)
Chiral Column: Chiralcel OD-H
racemic
227
Conclusion
A series of chiral amino oxazolines were synthesized and screened as organocatalysts
for asymmetric intermolecular aldol reaction between acetone and aromatic aldehydes.
The reaction works well with a range of aromatic aldehydes showing good to high
selectivity. The present new system of organocatalyst was effective for the asymmetric
aldol reaction for a wide range of aromatic aldehydes and isatin to accomplish the
asymmetric carbon-carbon bond forming reaction with a high selectivity of up to 91 %
ee.
We have also applied some of these aminooxazolines for copper catalyzed asymmetric
Henry reaction which exhibited moderate enatioinduction.
228
References
1) (a) Dalko, P. I.; Moisan, L. Angew. Chem. Int. Ed. 2004, 43, 5138. (b) Berkessel, A.;
Gröger, H. Asymmetric Organocatalysis: from biomimetic concepts to applications in
asymmetric synthesis, Wiley-VCH: Weinheim, Germany, 2005. (c) Enders, D.;
Grondal, C.; Hüttl, M. R. M. Angew. Chem. Int. Ed. 2007, 46, 1570. (d) Guillena, G.;
Ramón, D. J. Tetrahedron: Asymmetry 2006, 17, 1465. (e) Marigo, M.; Jørgensen, K.
A. Chem. Commun. 2006, 2001. (f) Guillena, G.; Nájera, C.; Ramón, D. J. Tetrahedron:
Asymmetry 2007, 18, 2249. (g) Bhanushali, M.; Zhao, C. -G. Synthesis, 2011, 1815. (h)
Bhanja, C.; Jena, S.; Nayak, S.; Mohapatra, S. Beilstein, J. Org. chem. 2012, 8, 1668. (i)
Heravi, M. M.; Asadi, S. Tetrahedron: Asymmetry 2012, 23, 1431. (j) See also special
issues on asymmetric organocatalysis: I) Acc. Chem. Res. 2004, 37, issue 8. II) Adv.
Synth. Catal. 2004, 346, issue 9-10. III) Chem. Rev. 2007, 107, issue 12.
2) (a) List, B.; Lerner, R. A.; Barbas III, C. F. J. Am. Chem. Soc. 2000, 122, 2395. (b)
Notz, W.; List, B. J. Am. Chem. Soc. 2000, 122, 7386. (c) Sakthievel, K.; Notz, W.; Bui,
T.; Barbas III, C. F. J. Am. Chem. Soc. 2001, 123, 5260.
3) Zimmerman, H. E.; Traxler, M. D. J. Am. Chem. Soc. 1957, 79, 1920.
4) Kim, H.Y.; Oh, K. Org. Lett. 2011, 13, 1306.
5) Rambo, R. S.; Schneider, P. H. Tetrahedron: Asymmetry 2010, 21, 2254.
6) (a) Paradowska, J.; Rogozinńska, M.; Mlynarski, J. Tetrahedron Lett. 2009, 50, 1639.
(b) Li, L.; Klauber, E. G.; Seidel, D. J. Am. Chem. Soc. 2008, 130, 12248.
7) (a) Luppi, G.; Cozzi, P. G.; Monari, M.; Kaptein, B.; Broxterman, Q. B.; Tomasini, C.
J. Org. Chem. 2005, 70, 7418. b) Davie, E. A. C.; Mennen, S. M.; Xu, Y.; Miller, S. J.
Chem. Rev. 2007, 107, 5759.
8) (a) Dwivedi, N.; Bisht, S. S.; Tripathi, R. P. Carbohydrate Res. 2006, 341, 2737. (b)
Shen, C.; Shen, F.; Xia, H.; Zhang, P.; Chen, X. Tetrahedron: Asymmetry 2011, 22,
708.
9) (a) Doherty, S.; Knight, J. G.; McRae, A.; Harrington, R. W.; Clegg, W. Eur. J. Org.
Chem. 2008, 1759. (b) Sathapornvajana, S.; Vilaivan, T. Tetrahedron 2007, 63, 10253.
(c) Kristensen, T. E.; Vestli, K.; Jakobsen, M. G.; Hansen, F. K.; Hansen, T. J. Org.
Chem. 2010, 75, 1620.
10) Zhang, H. F.; Zhao, W. S.; Zou, J.; Liu, Y.; Li, R. T.; Cui, Y. C. Chirality 2009, 21,
492.
229
11) Zou, J.; Zhao, W. S.; Li, R. T.; Zhang, H. F.; Cui, Y. C. J. Appl. Polym. Sci. 2010, 118,
1020.
12) Nie, J.; Li, X. –J.; Zheng, F. –G.; Cui, S.; Ma, J. –A. J. Fluorine Chem. 2011, 132, 468.
13) (a) Brown, S. P.; Brochu, M. P.; Sinz, C. J.; MacMillan, D. W. C. J. Am.Chem. Soc.
2003, 125, 10808. (b) Zhong, G. Angew. Chem., Int. Ed. 2003, 42, 4247. (c) Hayashi,
Y.; Yamaguchi, J.; Hibino, K.; Shoji, M. Tetrahedron Lett. 2003, 44, 8293. (d) Bøgevig,
A.; Sunde´n, H.; Co´rdova, A. Angew. Chem., Int. Ed. 2004, 43, 1109. (e) Hayashi, Y.;
Yamaguchi, J.; Sumiya, T.; Shoji, M. Angew. Chem., Int. Ed. 2004, 43, 1112.
14) (a) Kacprzak, K.; Gawroski, J. Synthesis 2001, 961. (b) Chen, Y.; McDaid, P.; Deng, L.
Chem. Rev. 2003, 103, 2965. (c) Tian, S. –K.; Chen, Y. –C.; Hang, J.; Tang, L.;
McDaid, P.; Deng, L. Acc. Chem. Res. 2004, 37, 621. (d) Bhanushali, M.; Zhao, C. –G.
Synthesis 2011, 1815.
15) (a) Wang, Y.; Li, H.; Zu, L.; Wang, W. Org. Lett. 2006, 8, 1391. (b) Cantarero, J. –L.;
Cid, M. –B.; Poulsen, B. –T.; Bella, M.; Ruano, J. L. G.; Jorgensen, K. A. J. Org.
Chem. 2007, 72, 7062. (c) Guo, C.; Xue, M. –X.; Zhu, M. –K.; Gong, L. –Z. Angew.
Chem. Int. Ed. 2008, 47, 3414.
16) (a) Maruoka, K.; Ooi, T. Chem. Rev. 2003, 103, 3013. (b) Hashimoto, T.; Maruoka, K.
Chem. Rev. 2007, 107, 5656.
17) France, S.; Guerin, D. J.; Miller, S. J.; Lectka, T. Chem. Rev. 2003, 103, 2985.
18) Chen, J. R.; An, X. –L.; Zhu, X. –Y.; Wang, X. –F.; Xiao, W. –J. J. Org. Chem. 2008,
73, 6006.
19) Yang, Y.; He, Y. –H.; Guan, Z.; Huang, W. –D. Adv. Synth. Catal. 2010, 352, 2579.
20) Kinsella, M.; Duggan, P. G.; Lennon, C. M. Tetrahedron: Asymmetry 2011, 22, 1423.
21) Guo, Q.; Bhanushali, M.; Zhao, C. –Q. Angew. Chem. Int. Ed. 2010, 49, 9460.
22) Henry, L. Compt. Rend. Hebd. Seances. Acad. Sci. 1895, 120, 1265.
23) Sasai, H., Suzuki, T., Itoh, N., Arai, S., Shibasaki, M. Tetrahedron Lett. 1993, 34, 855.
24) Luzzio, F.A. Tetrahedron 2001, 57, 915.
25) Handa, S.; Gnanadesikan, V.; Matsunaga, S.; Shibashaki, M. J. Am. Chem. Soc. 2007,
129, 4900.
26) (a) Palomo, C.; Oiarbide, M.; Mielgo, A. Angew. Chem. Int. Ed. 2004, 43, 5442. (b)
Boruwa, J.; Gogoi, N.; Saikia, P.; Barua, N. C. Tetrahedron: Asymmetry 2006, 17,
3315. (c) Palomo, C.; Oiarbide, A.; Laso, A. Eur. J. Org. Chem. 2007, 2561.
230
27) (a) Christensen, C.; Juhl, K.; Jørgensen, K. A. Chem. Commun 2001, 2222. (b)
Christensen, C.; Juhl, K.; Hazell, R. G.; Jørgensen, K. A. J. Org. Chem. 2002, 67, 4875.
(c) Lang, K.; Park, J.; Hong, S. J. Org. Chem. 2010, 75, 6424. (d) Jin, W.; Li, X.;
Huang, Y.; Wu, F.; Wan, B. Chem. Eur. J. 2010, 16, 8259.(e) Jin, W.; Li, X.; Wan, B. J.
Org. Chem. 2011, 76, 484. (f) Gualandi, A.; Cerisoli, L.; Stoeckli-Evans, H.; Savoia, D.
J. Org. Chem. 2011, 76, 3399. 28) Zhou, Y.; Gong, Y. Eur. J. Org. Chem. 2011, 6092.
29) Lu, S. –F.; Du, D. –M.; Zhang, S. –W.; Xu, J. Tetrahedron: Asymmetry 2004, 15, 3433.
30) (a) Kawthekar, R. B.; Chakka, S. K.; Francis, V.; Andersson, P. G.; Kruger, H.;
Maguire, G. E. M.; Govender, T. Tetrahedron: Asymmetry 2010, 21, 846. (b) Ginotra,
S. K.; Singh, V. K. Org. Biomol. Chem. 2007, 5, 3932.
31) (a) Lai, G.; Wang, S.; Wang, Z. Tetrahedron: Asymmetry 2008, 19, 1813. (b) Yang, W.;
Du, D. –M. Eur. J. Org. Chem. 2011, 1552.
32) Kowalczyk, R.; Sidorowicz, L.; Skarzewski, J. Tetrahedron: Asymmetry 2008, 19,
2310.
33) Chandrasekhar, S.; Ramakrishna Reddy, N.; Shameem Sultana, S.; Narsihmulu
Venkatram Reddy, K. Tetrahedron 2006, 62, 338.
34) Lei, M.; Shi, L.; Li, G.; Chen, S.; Fang, W.; Ge, Z.; Cheng, T.; Li, R. Tetrahedron 2007,
63, 7892.
35) Daka, P.; Xu, Z.; Alexa, A.; Wang, H. Chem. Commun. 2011, 47, 224.
36) Chimni, S. S.; Mahajan, D. Tetrahedron 2005, 61, 5019.
37) Tong, S.-T.; Harris, P. W. R.; Barker, D.; Brimble, M. A. Eur. J. Org. Chem. 2008, 164.
38) Zhou, Y.; Shan, Z. Tetrahedron: Asymmetry 2006, 17, 1671.
39) Tang, Z.; Jiang, F.; Yu, L.-T.; Cui, X.; Gong, L.-Z.; Mi, A.-Q.; Jiang, Y.-Z.; Wu, Y.-D.
J. Am. Chem. Soc. 2003, 125, 5262.
40) Da, C.-S.; Che, L.-P.; Guo, Q.-P.; Wu, F.-C.; Ma, X.; Jia, Y.-N. J. Org. Chem. 2009, 74,
2541.
41) Evans, D. A.; Seidel, D.; Rueping, M.; Lam, H. W.; Shaw, J. T.; Downey, C. W. J. Am.
Chem. Soc., 2003, 125, 12692.